ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53, and mismatch repair genes (MLH1, MSH2, MSH6, PMS2, EPCAM)
Posted on: Apr 23, 2019 02:44PM
Genetic Testing Rates Are Low in Women Diagnosed With Breast Cancer, Ovarian Cancer
April 18, 2019
Only about 25% of women diagnosed with breast cancer and about 31% of women diagnosed with ovarian cancer have genetic testing. Read more...